OpenURL Connection Search

Select item for more details and to access through your institution.

Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy.
Published in:
Gene Therapy, 2005, v. 12, n. 22, p. 1633, doi. 10.1038/sj.gt.3302531
By:
- Kawashita, Y.;
- Ohtsuru, A.;
- Miki, F.;
- Kuroda, H.;
- Morishita, M.;
- Kaneda, Y.;
- Hatsushiba, K.;
- Kanematsu, T.;
- Yamashita, S.
Publication type:
Article
AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL.
Published in:
Gene Therapy, 2005, v. 12, n. 22, p. 1618, doi. 10.1038/sj.gt.3302549
By:
- Sondhi, D.;
- Peterson, D. A.;
- Giannaris, E. L.;
- Sanders, C. T.;
- Mendez, B. S.;
- De, B.;
- Rostkowski, A. B.;
- Blanchard, B.;
- Bjugstad, K.;
- Sladek, J. R.;
- Redmond Jr., D. E.;
- Leopold, P. L.;
- Kaminsky, S. M.;
- Hackett, N. R.;
- Crystal, R. G.
Publication type:
Article
Optimization of adenovirus-mediated endothelial nitric oxide synthase delivery in rat hindlimb ischemia.
Published in:
Gene Therapy, 2005, v. 12, n. 22, p. 1640, doi. 10.1038/sj.gt.3302563
By:
- Yan, J.;
- Tang, G. L.;
- Wang, R.;
- Messina, L. M.
Publication type:
Article
Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients.
Published in:
Gene Therapy, 2005, v. 12, n. 22, p. 1651, doi. 10.1038/sj.gt.3302565
By:
- Vilquin, J.-T.;
- Marolleau, J.-P.;
- Sacconi, S.;
- Garcin, I.;
- Lacassagne, M.-N.;
- Robert, I.;
- Ternaux, B.;
- Bouazza, B.;
- Larghero, J.;
- Desnuelle, C.
Publication type:
Article
Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
Published in:
Gene Therapy, 2005, v. 12, n. 22, p. 1608, doi. 10.1038/sj.gt.3302581
By:
- Kuppuswamy, M;
- Spencer, J. F.;
- Doronin, K.;
- Tollefson, A. E.;
- Wold, W. S. M.;
- Toth, K.
Publication type:
Article
Gene Therapy Progress and Prospects: Fetal gene therapy – first proofs of concept – some adverse effects.
Published in:
Gene Therapy, 2005, v. 12, n. 22, p. 1601, doi. 10.1038/sj.gt.3302632
By:
- Coutelle, C.;
- Themis, M.;
- Waddington, S. N.;
- Buckley, S. M. K.;
- Gregory, L. G.;
- Nivsarkar, M. S.;
- David, A. L.;
- Peebles, D.;
- Weisz, B.;
- Rodeck, C.
Publication type:
Article

Found: 6

Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy.

AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL.

Optimization of adenovirus-mediated endothelial nitric oxide synthase delivery in rat hindlimb ischemia.

Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients.

Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.

Gene Therapy Progress and Prospects: Fetal gene therapy – first proofs of concept – some adverse effects.